Vident Investment Advisory’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,983
Closed -$674K 1099
2023
Q2
$674K Buy
5,983
+3,487
+140% +$369K 0.02% 581
2023
Q1
$261K Buy
+2,496
New +$261K 0.01% 1003
2022
Q4
Sell
-42,622
Closed -$3.71M 1354
2022
Q3
$3.71M Buy
42,622
+7,618
+22% +$692K 0.12% 203
2022
Q2
$2.73M Sell
35,004
-1,092
-3% -$90.2K 0.08% 281
2022
Q1
$3.08M Buy
36,096
+2,514
+7% +$241K 0.08% 271
2021
Q4
$4.03M Buy
33,582
+3,803
+13% +$472K 0.1% 223
2021
Q3
$3.68M Buy
29,779
+222
+0.8% +$28.6K 0.11% 187
2021
Q2
$3.55M Buy
29,557
+8,425
+40% +$962K 0.11% 193
2021
Q1
$2.22M Buy
21,132
+2,429
+13% +$246K 0.07% 332
2020
Q4
$1.9M Buy
18,703
+3,242
+21% +$305K 0.08% 303
2020
Q3
$1.3M Sell
15,461
-582
-4% -$45.3K 0.06% 415
2020
Q2
$1.04M Buy
16,043
+6,727
+72% +$444K 0.05% 462
2020
Q1
$607K Buy
9,316
+6,195
+198% +$488K 0.04% 528
2019
Q4
$246K Buy
+3,121
New +$243K 0.02% 653
2018
Q3
Sell
-6,286
Closed -$424K 1015
2018
Q2
$424K Buy
6,286
+244
+4% +$17.7K 0.02% 716
2018
Q1
$471K Buy
+6,042
New +$447K 0.02% 637
2015
Q4
Sell
-124
Closed -$4K 857
2015
Q3
$4K Sell
124
-696
-85% -$23.4K ﹤0.01% 931
2015
Q2
$30K Buy
+820
New +$29.8K ﹤0.01% 885

Other funds holding XYL

Vident Investment Advisory's XYL Position: Q3 2023 in Review

Vident Investment Advisory sold out of Xylem (XYL) in Q3 2023, closing a stake of 5,983 shares — an estimated $674K sold.

Vident Investment Advisory first reported a position in XYL in Q2 2015 and held it in 18 quarters. The position peaked at $4.03M in Q4 2021. 872 funds tracked by Wall St. Rank hold XYL as of Q3 2023.

  • Vident Investment Advisory reported no remaining Xylem position as of Q3 2023 after selling out during the quarter.
  • Vident Investment Advisory sold 5,983 Xylem shares in Q3 2023, an estimated $674K.
  • Vident Investment Advisory first reported a position in Xylem in Q2 2015 and held it in 18 quarters.
  • Vident Investment Advisory's Xylem position peaked at $4.03M in Q4 2021.
  • 872 funds tracked by Wall St. Rank held Xylem as of Q3 2023.

Based on Vident Investment Advisory's 13F filing for Q3 2023.